Home › Down Syndrome › Missouri › St. Louis
Down Syndrome clinical trials in St. Louis, MO
4 studies for Down Syndrome are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Cardinal Glennon Children's Medical Center, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital Saint Louis, St Louis
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
RecruitingObservational study
- Washington University School of Medicine, St Louis
Collaboration for Down Syndrome Progress (CDP)
RecruitingObservational study
- Washington University in St. Louis, St Louis
Trial-Ready Cohort-Down Syndrome (TRC-DS)
RecruitingObservational study
- Washington University, St. Louis, St Louis
About Down Syndrome
About 1 in 700 babies are born with the birth defect known as Down Syndrome. Learn about the different Down Syndrome types and related health issues.
More about Down Syndrome on MedlinePlus
Down Syndrome trials in other cities
- Aurora, CO7 studies
- Houston, TX6 studies
- Phoenix, AZ6 studies
- Durham, NC6 studies
- Cincinnati, OH5 studies
- Nashville, TN5 studies
- Kansas City, KS5 studies
- Orlando, FL5 studies
- Ann Arbor, MI5 studies
- Cleveland, OH5 studies
- Philadelphia, PA5 studies
- Atlanta, GA4 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Prostate Cancer46 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.